Back

Watch Compare

Xtant Medical Holdings, Inc.

Data quality: 100%

XTNT

NYSE Manufacturing Measuring & Analyzing Instruments

$0.49

▲ $0.01 (3.15%)

Mkt Cap: 67.93 M

Price

$0.49

Mkt Cap

67.93 M

Day Range

$0.45 — $0.51

52-Week Range

$0.34 — $0.95

Volume

136,451

Open $0.47

50D / 200D Avg

$0.59

17.55% below

50D / 200D Avg

$0.65

25.91% below

Quick Summary

Key Takeaways

Revenue grew 24.77% annually over 5 years — strong growth

ROE of 10.06% — decent returns on equity

Debt/Equity of 0.35 — conservative balance sheet

Generating 10.16 M in free cash flow

P/E of 13.66 — trading at a low valuation

Revenue growth is decelerating — 1Y growth trails 5Y average by 10.56%

Growth

Revenue Growth (5Y)

24.77%

Above sector avg (1.82%)

Revenue (1Y)14.21%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

10.06%

Above sector avg (-53.41%)

ROIC7.20%

Net Margin3.71%

Op. Margin5.44%

Safety

Debt / Equity

0.35

Above sector avg (0.31)

Current Ratio2.21

Interest Coverage1.98

Valuation

PE (TTM)

13.66

Above sector avg (-1.48)

P/B Ratio1.35

EV/EBITDA5.99

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)

Metric	Stock	Sector Median
P/E	13.7	-1.5
P/B	1.4	1.6
ROE %	10.1	-53.4
Net Margin %	3.7	-41.5
Rev Growth 5Y %	24.8	1.8
D/E	0.4	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	14.21%	Revenue Growth (3Y)	21.11%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	174.50%
Revenue Growth (5Y)	24.77%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	133.93 M	Net Income (TTM)	4.97 M
ROE	10.06%	ROA	4.74%
Gross Margin	62.92%	Operating Margin	5.44%
Net Margin	3.71%	Free Cash Flow (TTM)	10.16 M
ROIC	7.20%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	0.35	Current Ratio	2.21
Interest Coverage	1.98	Asset Turnover	1.28
Working Capital	42.83 M	Tangible Book Value	36.02 M
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	13.66	Forward P/E	N/A
P/B Ratio	1.35	P/S Ratio	0.51
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	5.99	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	14.96%
Market Cap	67.93 M	Enterprise Value	74.94 M
Per Share
EPS (Diluted TTM)	0.03	Revenue / Share	0.96
FCF / Share	0.07	OCF / Share	0.09
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	1.78%	FCF Conversion	204.38%
SBC-Adj. FCF	6.86 M	Growth Momentum	-10.56

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	133.93 M	117.27 M	91.30 M	57.97 M	55.26 M
Net Income	4.97 M	-16.45 M	660,000.0	-8.49 M	-4.85 M
EPS (Diluted)	0.03	-0.12	0.01	-0.09	-0.06
Gross Profit	84.27 M	68.22 M	55.47 M	32.14 M	32.49 M
Operating Income	7.28 M	-12.07 M	-10.16 M	-6.76 M	-3.85 M
EBITDA	—	—	—	—	—
R&D Expenses	2.10 M	2.39 M	1.34 M	915,000.0	870,000.0
SG&A Expenses	—	—	—	—	—
D&A	5.22 M	4.22 M	3.17 M	1.29 M	1.33 M
Interest Expense	3.67 M	4.16 M	2.94 M	1.69 M	995,000.0
Income Tax	2.03 M	187,000.0	-1.70 M	69,000.0	296,000.0

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	94.15 M	93.84 M	92.61 M	60.23 M	54.69 M
Total Liabilities	43.19 M	50.87 M	41.26 M	26.06 M	23.81 M
Shareholders' Equity	50.95 M	42.96 M	51.35 M	34.17 M	30.88 M
Total Debt	11.03 M	22.04 M	17.17 M	9.69 M	11.79 M
Cash & Equivalents	17.05 M	6.20 M	5.72 M	20.30 M	18.24 M
Current Assets	78.25 M	67.12 M	64.87 M	49.32 M	44.33 M
Current Liabilities	29.48 M	28.58 M	22.99 M	15.22 M	11.08 M